BACKGROUND: Integrase defective lentiviral vectors (IDLV) represent a promising delivery system for immunization purposes. Human dendritic cells (DC) are the main cell types mediating the immune response and are readily transduced by IDLV, allowing effective triggering of in vitro expansion of antigen-specific primed CD8+ T cells. However, IDLV expression in transduced DC is at lower levels than those of the integrase (IN) competent counterpart, thus requiring further improvement of IDLV for future use in the clinic. RESULTS: In this paper we show that the addition of simian immunodeficiency (SIV)-Vpx protein in the vector preparation greatly improves transduction of human and simian DC, but not of murine DC, thus increasing the ability of transduced DC to act as functional antigen presenting cells, in the absence of integrated vector sequences. Importantly, the presence of SIV-Vpx allows for using lower dose of input IDLV during in vitro transduction, thus further improving the IDLV safety profile. CONCLUSIONS: These results have significant implications for the development of IDLV-based vaccines.

Simian immunodeficiency virus-Vpx for improving integrase defective lentiviral vector-based vaccines / Negri, Dr; Rossi, A; Blasi, M; Michelini, Z; Leone, P; Chiantore, Mv; Baroncelli, S; Perretta, G; Cimarelli, A; Klotman, Me; Cara, A. - In: RETROVIROLOGY. - ISSN 1742-4690. - 9:(2012). [10.1186/1742-4690-9-69]

Simian immunodeficiency virus-Vpx for improving integrase defective lentiviral vector-based vaccines

Rossi A;
2012

Abstract

BACKGROUND: Integrase defective lentiviral vectors (IDLV) represent a promising delivery system for immunization purposes. Human dendritic cells (DC) are the main cell types mediating the immune response and are readily transduced by IDLV, allowing effective triggering of in vitro expansion of antigen-specific primed CD8+ T cells. However, IDLV expression in transduced DC is at lower levels than those of the integrase (IN) competent counterpart, thus requiring further improvement of IDLV for future use in the clinic. RESULTS: In this paper we show that the addition of simian immunodeficiency (SIV)-Vpx protein in the vector preparation greatly improves transduction of human and simian DC, but not of murine DC, thus increasing the ability of transduced DC to act as functional antigen presenting cells, in the absence of integrated vector sequences. Importantly, the presence of SIV-Vpx allows for using lower dose of input IDLV during in vitro transduction, thus further improving the IDLV safety profile. CONCLUSIONS: These results have significant implications for the development of IDLV-based vaccines.
2012
01 Pubblicazione su rivista::01a Articolo in rivista
Simian immunodeficiency virus-Vpx for improving integrase defective lentiviral vector-based vaccines / Negri, Dr; Rossi, A; Blasi, M; Michelini, Z; Leone, P; Chiantore, Mv; Baroncelli, S; Perretta, G; Cimarelli, A; Klotman, Me; Cara, A. - In: RETROVIROLOGY. - ISSN 1742-4690. - 9:(2012). [10.1186/1742-4690-9-69]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1405960
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 21
  • ???jsp.display-item.citation.isi??? 20
social impact